• Journal of Microbiology and Biotechnology
• /
• 제24권12호
• /
• pp.1728-1735
• /
• 2014

Scrub typhus, caused by infection with Orientia tsutsugamushi, is a mite-borne zoonotic disease endemic to the Asian-Pacific region. In Korea, the incidence of this disease has increased with climate changes, and over 10,000 cases of infection were reported in 2013. Although this infection is treatable with antibiotics such as doxycycline and azithromycin, an effective prophylactic vaccine against O. tsutsugamushi would be more desirable for preventing scrub typhus in endemic areas. In this study, we investigated the 56-kDa type-specific antigen (TSA56), which is a major outer membrane protein of O. tsutsugamushi, as a vaccine candidate. Intranasal immunization of recombinant TSA56 (rec56) induced a higher level of TSA56-specific IgG than that induced by intramuscular immunization of tsa56-expressing DNA (p56). Both types of immunization induced a cell-mediated immune response to TSA56, as demonstrated by the splenic cell proliferation assay. Mice immunized with p56, followed by rec56 plus heat-labile enterotoxin B subunit from E. coli, had a stronger protection from a homologous challenge with the O. tsutsugamushi Boryong strain than with other combinations. Our preliminary results suggest that an effective human vaccine for scrub typhus can include either recombinant TSA56 protein or tsa56-expressing DNA, and provide the basis for further studies to optimize vaccine performance using additional antigens or different adjuvants.

• Journal of Microbiology and Biotechnology
• /
• 제25권2호
• /
• pp.280-287
• /
• 2015

Current influenza vaccines are produced in embryonated chicken eggs. However, egg-based vaccines have various problems. To address these problems, recombinant protein vaccines have been developed as new vaccine candidates. Unfortunately, recombinant proteins frequently encounter aggregation and low stability during their biogenesis. It has been previously demonstrated that recombinantly expressed proteins can be greatly stabilized with high solubility by fusing stabilizing peptide (SP) derived from the C-terminal acidic tail of human synuclein (ATS). To investigate whether SP fusion proteins can induce protective immunity in mice, we produced influenza HA and SP fusion protein using a baculovirus expression system. In in vitro tests, SP-fused recombinant HA1 (SP-rHA1) was shown to be more stable than recombinant HA1 (rHA1). Mice were immunized intramuscularly with baculovirus-expressed rHA1 protein or SP-rHA1 protein ($2{\mu}g/mouse$) formulated with aluminum hydroxide. Antibody responses were determined by ELISA and hemagglutination inhibition assay. We observed that SP-rHA1 immunization elicited HA-specific antibody responses that were comparable to rHA1 immunization. These results indicate that fusion of SP to rHA1 does not negatively affect the immunogenicity of the vaccine candidate. Therefore, it is possible to apply SP fusion technology to develop stable recombinant protein vaccines with high solubility.

• KSBB Journal
• /
• 제18권4호
• /
• pp.324-328
• /
• 2003

도꼬마리 추출물의 발암성의 유무를 검토하기 위하여 시험균 S. typhimurium TA98 및 TA100에 대한 변이원성 실험 결과, 추출물 XE-N과 XEA-N의 농도가 증가해도 TA 98 및 TA100 두 균주의 복귀변이 colony 수가 대조구에 비해 변화가 크지 않은 점을 미루어 보아 각 추출물은 변이원성이 없는 것으로 확인되었다. 도꼬마리 추출물 XEA-A, XEA-B 및 XE-A)의 $H_2O$$_2$로 유도된 세포 독성에 대한 억제효과는 각각 58%, 53%, 63%로서 생존율이 2배 이상 증가하였다. 면역 증강 활성은 TNF의 경우 XE-N 추출물에서 2.7배로 가장 높은 활성을 나타내었으며 XEA-N 추출물에서도 2.3배로 높은 활성을 나타내었다. IL-1$\beta$의 생성은 XE-B 추출물에서 높게 나타났으며, IL-2의 생성에는 뚜렷한 활성을 나타내지 않았다. 도꼬마리 추출물 및 정제물을 이용하여 동물에 강력한 발암물질인 MNNG를 투여한 후 항산화 효소계를 측정한 결과, 조직의 해독물질인 glutathione (GSH)의 함량이 도꼬마리 정제물 0.2% 투여군에서 약 44.6%, 도꼬마리 추출물 투여군에서 약 41.5% 증가되었다. 또한 도꼬마리 추출물 및 정제물질은 암억제 유전자인 p53의 발현을 매우 증가시켰다. 이상의 결과에서 도꼬마리 추출물은 전반적으로 항산화능, 면역증강효과, 암 예방효과 등의 기능성이 있는 것으로 입증되었으며, 각 기능에 따른 다양한 물질을 분리하여 신소재로의 개발 가능성이 큰 약제임이 확인되었다.

• International Journal of Oral Biology
• /
• 제34권3호
• /
• pp.131-135
• /
• 2009

The sublingual locus has recently received great attention as a delivery site for various immunotherapies, including those that induce allergen-specific tolerance, and for vaccines that generate protective immunity. To further understand the immune functions of the human sublingual mucosa, we characterized the distribution of various immunocytes therein by immunohistochemistry. We identified professional antigen presenting cells (APCs), including Langerhans cells (LCs) and macrophages. $CD1a^+$ and $langerin^+$ LCs were further found to be distributed in the basal and supra-basal layers of the epithelium, and macrophages were identified in the lamina propria. HLA-$DR^+$ cells were observed in both the epithelium and the lamina propria, which mirrors the tissue distribution of LCs and macrophages within these tissues. $CD3^+$, $CD4^+$, and $CD8^+$ T cells were found to be distributed along the basal layer of the epithelium and also in the lamina propria. Although B cells, plasma cells, and $Foxp3^+$ regulatory T cells (Tregs) were only occasionally observed in the human sublingual mucosa in the absence of inflammation, they did show enrichment at inflammatory sites. Hence, we have further elucidated the immune cell component distribution in human sublingual mucosa.

• 대한수의학회지
• /
• 제56권4호
• /
• pp.255-260
• /
• 2016

The Ecklonia cava Kjellman by-product (ECBP) as a feed additive was evaluated in improvement of productivity and immune enhancement against Salmonella Gallinarum (SG). Lohmann Brown chickens proved SG-free were randomly divided into 3 groups of 8 chickens each. Chickens were fed with the experimental diet treatment: T0, Non treatment-commercial feed; T1, commercial feed with 0.5% ECBP; T2, commercial feed with 0.1% Lactobacillus plantarum. In this study, we evaluated the effect of T1 and T2 groups on the body weight and protective efficacy against SG in chickens. The results demonstrated that treatment of T1 group as a feed additive affected significantly body weight gaining in chickens. In addition, T1 group showed a significant different colonization of SG when compared to T2 and T0 groups. We also studied that serum IgG and $interferon-{\gamma}$ levels were significantly different compared with other treatment groups. Therefore, we suggest that ECBP can be used as a good candidate of feed additives in chicken industry.

• 대한수의학회지
• /
• 제58권1호
• /
• pp.9-16
• /
• 2018

A preliminary study into the protective mechanisms of adaptive immunity against porcine reproductive and respiratory syndrome virus (PRRSV) in piglets (n = 9) born to a gilt challenged intranasally with a type-2 PRRSV. Immune parameters (neutralizing antibodies, $CD3^+CD4^+$, $CD3^+CD8^+$, $CD3^+CD4^+CD8^+$ T-lymphocytes, and PRRSV-specific interferon $(IFN)-{\gamma}$ secreting T-lymphocytes) were compared with infection parameters (macro- and microscopic lung lesion, and PRRSV-infected porcine alveolar macrophages ($CD172{\alpha}^+PRRSV-N^+\;PAM$) as well as with plasma and lymphoid tissue viral loads. Percentages of three T-lymphocyte phenotypes in 14-days post-birth (dpb) peripheral blood mononuclear cell (PBMC) had significant negative correlations with percentages of $CD172{\alpha}^+PRRSV-N^+\;PAM$ (p < 0.05) as well as with macroscopic lung lesion (p < 0.01). Plasma and tissue viral loads had significant (p < 0.05) negative correlations with $CD3^+CD4^+CD8^+$ T-lymphocyte percentage in PBMC. Frequencies of $CD3^+CD8^+$ and $CD3^+CD4^+$ T-lymphocytes in 14-dpb PBMC had significant negative correlations with of lymph node (p = 0.04) and lung (p = 0.002) viral loads. $IFN-{\gamma}$-secreting T-lymphocytes frequency had a significant negative correlation with gross lung lesion severity (p = 0.002). However, neutralizing antibody titers had no significant negative correlation (p > 0.1) with infection parameters. The results indicate that T-lymphocytes contribute to controlling PRRSV replication in young piglets born after in-utero infection.

• 수산해양교육연구
• /
• 제22권4호
• /
• pp.529-536
• /
• 2010

This study was conducted to effect of extruded pellets (EPs) and moist pellet (MP) diet on growth and fish health parameters in farm cultured olive flounder Paralichthys olivaceus. Two replicate groups of 2,600 fish per each tank (initial weight of $30.1{\pm}0.2$ g) were fed one of the three EPs (EP1, EP2 and CEP) and one MP for 13 months. In field feeding experiment conducted in commercial flounder farm, survival, growth (30-600 g) and condition factor of fish fed experimental EP1 and EP2 were comparable to those of fish fed MP, but considerably higher feed efficiency and protein efficiency ratio were observed in fish fed experimental EPs. Viable cell counts from diet and water from MP diet were considerably higher than those from EP diet, and lysozyme activity from EP diet was higher than that from MP diet. GOT and GPT of fish fed the EP diet were considerably lower than those from MP group, but total protein and glucose concentration of fish fed the EP groups were not significantly different from that of fish fed the MP. Therefore, these results strongly suggest that EP diets could be developed to replace MP diet without adverse effects on growth performance and to enhance the immunity and protective ability of olive flounder against fish disease such as Vibro, Edwardsiella and Strptococcus.

• 대한수의학회지
• /
• 제18권1호
• /
• pp.51-60
• /
• 1978

돼지의 전염성위축성비염(傳染性萎縮性鼻炎)의 주요한 병원균(病原菌)이라고 생각되는 Bordetella bronchiseptica(이하(以下)B균(菌)) 자연감염돈분리유내균주(自然感染豚分離由來菌株)를 사용하여 mouse 비강내정착성(鼻腔內定着性)에 관(對)한 사균면역(死菌免疫)의 효과(效果)를 검토하고자, 먼저 상변리(相變異)에 따르는 균(菌)의 독역(毒力)과 감염방어성(感染防禦性)을 비교함과 동시에, I 상균불활화예방액(相菌不活化豫防液)의 면역원성(免疫原性)에 관(對)한 기초적인 검토를 실시하였고, 이에 계속하여 생균비강내접종(生菌鼻腔內接種)에 따르는 균(菌)의 정착성(定着性)과 혈중응집(血中凝集) 항체(抗體)의 경시적(經時的)인 추이(推移)를 검토하였다. 얻어진 성적을 요약하면 다음과 같다. 1. B균(菌) I 상균(相菌)(W-1029주(株))의 독역(毒力)은 III 상균(相菌)(H-969주(株))에 비하여 독역(毒力)이 강하였으며, I 상균(相菌)은 감염방어성(感染防禦性)을 보유하고 있었으나 III 상균(相菌)은 감염방어성(感染防禦性)이 전혀 없었다. 2. B균(菌) I 상균사균면역(相菌死菌免疫)에 있어서 formalin과 merthiolate 처리(處理) 및 불활화온도(不活化溫度)($0^{\circ}C$및 $37^{\circ}C$)간(間)에는 현저한 면역원성(免疫原性)의 차이는 인정할 수 없었다. 3. 사균면역(死菌免疫)을 실시한 mouse 군(群)에 생균(生菌)의 경비접종(經鼻接種)에 의하여 경시적(經時的)으로 균(菌)의 호흡기도내(呼吸氣道內)의 정착성(定着性)과 혈중응집항체가(血中凝集抗體價)의 추이(推移)를 보았던 바, 비면역대조군(非免疫對照群)에 비하여 면역군(免疫群)은 현저한 면역효과(免疫效果)를 나타내었으나, 면역군(免疫群)에서 간헐적(間歇的)인 배균(排菌)이 상당기간에 걸쳐 인정되었으며 또한 응집항체가(凝集抗體價)의 상승에 따르는 비강내정착균(鼻腔內定着菌)의 완전소실(完全消失)은 다소 곤난함이 인정되었다. 이상(以上)의 성적(成積)으로 B균사균항원(菌死菌抗原)을 사용하여 고도(高度)의 면역(免疫)을 시킴으로서 비강내(鼻腔內)에 있어서의 B균(菌)의 정착(定着)을 조지(阻止)할 수 있는 가능성(可能性)이 시사(示唆)되나 항체가(抗體價)의 상승(上昇)에 따르는 균(菌)이 비강내(鼻腔內)에서 완전 소실(消失)이 다소 곤난한 점은 본균(本菌)과 호흡기도점막감염(呼吸器道粘膜感染)의 실태(實態)를 시사(示唆)하는 것으로 보아진다.

• 한국축산식품학회지
• /
• 제34권6호
• /
• pp.829-835
• /
• 2014

Inflammatory bowel disease (IBD) is caused by dysregulation of colon mucosal immunity and mucosal epithelial barrier function. Recent studies have reported that lipoteichoic acid (LTA) from Lactobacillus plantarum K8 reduces excessive production of pro-inflammatory cytokine. In this study, we investigated the preventive effects of lysate of Lb. plantarum K8 in dextran sulfate sodium (DSS)-induced colitis. Male Sprague-Dawley rats were orally pretreated with lysate of Lb. plantarum K8 (low dose or high dose) or live Lb. plantarum K8 prior to the induction of colitis using 4% DSS. Disease progression was monitored by assessment of disease activity index (DAI). Histological changes of colonic tissues were evaluated by hematoxylin and eosin (HE) staining. Tumor necrosis factor-alpha (TNF-${\alpha}$), interleukin-6 (IL-6) levels were measured using enzyme-linked immunosorbent assay (ELISA). The colon mRNA expressions of TNF-${\alpha}$, IL-6, and toll like receptor-2 (TLR-2) were examined by quantitative real-time-transcription polymerase chain reaction (qPCR). Lysate of Lb. plantarum K8 suppressed colon shortening, edema, mucosal damage, and the loss of DSS-induced crypts. The groups that received lysate of Lb. plantarum K8 exhibited significantly decreased levels of the pro-inflammatory cytokines TNF-${\alpha}$ and IL-6 in the colon. Interestingly, colonic expression of toll like receptor-2 mRNA in the high-dose lysate of Lb. plantarum K8 group increased significantly. Our study demonstrates the protective effects of oral lysate of Lb. plantarum K8 administration on DSS-induced colitis via the modulation of pro-inflammatory mediators of the mucosal immune system.

• Journal of Ginseng Research
• /
• 제37권2호
• /
• pp.210-218
• /
• 2013

Numerous studies have suggested that Korean red ginseng (KRG) extract has various immune modulatory activities both in vivo and in vitro. In this study, we used a mouse model to examine the effects of orally administered KRG extract on immunity against herpes simplex virus (HSV). Balb/c mice were administered with 100, 200, and 400 mg/kg oral doses of KRG extract for 10 d and then vaginally infected with HSV. We found that KRG extract rendered recipients more resistant against HSV vaginal infection and further systemic infection, including decreased clinical severity, increased survival rate, and accelerated viral clearance. Such results appeared to be mediated by increased vaginal IFN-${\gamma}$ secretion. Moreover, increased mRNA expression of IFN-${\gamma}$, granzyme B, and Fas-ligand was identified in the iliac lymph node and vaginal tracts of KRG extract treated groups (200 and 400 mg/kg). These results suggest that the activities of local natural killer cells were promoted by KRG extract consumption and that KRG may be an attractive immune stimulator for helping hosts overcome HSV infection.